Crucell Announces PER.C6® Licensing Agreement with Pfizer Animal Health

19-Mar-2007

Crucell N.V. and Pfizer Animal Health announced the signing of a research license agreement for PER.C6®. The license agreement allows Pfizer Animal Health to use Crucell's PER.C6® cell technology in the production of a non-disclosed veterinary vaccine. Pfizer Animal Health has an option to convert the research license into a commercial agreement. Financial details were not disclosed.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances